Fuzzy method for pre-diagnosis of breast cancer from the Fine Needle Aspirate analysis

被引:16
|
作者
Sizilio, Glaucia R. M. A. [1 ,2 ]
Leite, Cicilia R. M. [3 ]
Guerreiro, Ana M. G. [1 ,2 ]
Doria Neto, Adriao D. [1 ,2 ]
机构
[1] Univ Fed Rio Grande Norte UFRN, Dept Comp Engn & Automat, DCA, UFRN CT DCA, BR-59072970 Natal, RN, Brazil
[2] Univ Fed Rio Grande Norte UFRN, Dept Biomed Engn, UFRN CT DCA, BR-59072970 Natal, RN, Brazil
[3] State Univ Rio Grande Norte UERN, Dept Informat, BR-59625620 Natal, RN, Brazil
关键词
Computational intelligence; Fuzzy logic; Fine needle aspirate; Decision support system; Breast cancer diagnosis; Telediagnosis; NEURAL-NETWORK;
D O I
10.1186/1475-925X-11-83
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Background: Across the globe, breast cancer is one of the leading causes of death among women and, currently, Fine Needle Aspirate (FNA) with visual interpretation is the easiest and fastest biopsy technique for the diagnosis of this deadly disease. Unfortunately, the ability of this method to diagnose cancer correctly when the disease is present varies greatly, from 65% to 98%. This article introduces a method to assist in the diagnosis and second opinion of breast cancer from the analysis of descriptors extracted from smears of breast mass obtained by FNA, with the use of computational intelligence resources - in this case, fuzzy logic. Methods: For data acquisition of FNA, the Wisconsin Diagnostic Breast Cancer Data (WDBC), from the University of California at Irvine (UCI) Machine Learning Repository, available on the internet through the UCI domain was used. The knowledge acquisition process was carried out by the extraction and analysis of numerical data of the WDBC and by interviews and discussions with medical experts. The PDM-FNA-Fuzzy was developed in four steps: 1) Fuzzification Stage; 2) Rules Base; 3) Inference Stage; and 4) Defuzzification Stage. Performance cross-validation was used in the tests, with three databases with gold pattern clinical cases randomly extracted from the WDBC. The final validation was held by medical specialists in pathology, mastology and general practice, and with gold pattern clinical cases, i.e. with known and clinically confirmed diagnosis. Results: The Fuzzy Method developed provides breast cancer pre-diagnosis with 98.59% sensitivity (correct pre-diagnosis of malignancies); and 85.43% specificity (correct pre-diagnosis of benign cases). Due to the high sensitivity presented, these results are considered satisfactory, both by the opinion of medical specialists in the aforementioned areas and by comparison with other studies involving breast cancer diagnosis using FNA. Conclusions: This paper presents an intelligent method to assist in the diagnosis and second opinion of breast cancer, using a fuzzy method capable of processing and sorting data extracted from smears of breast mass obtained by FNA, with satisfactory levels of sensitivity and specificity. The main contribution of the proposed method is the reduction of the variation hit of malignant cases when compared to visual interpretation currently applied in the diagnosis by FNA. While the MPD-FNA-Fuzzy features stable sensitivity at 98.59%, visual interpretation diagnosis provides a sensitivity variation from 65% to 98% (this track showing sensitivity levels below those considered satisfactory by medical specialists). Note that this method will be used in an Intelligent Virtual Environment to assist the decision-making (IVEMI), which amplifies its contribution.
引用
收藏
页数:21
相关论文
共 50 条
  • [41] PROGNOSIS OF LYMPHOMA FROM A FINE-NEEDLE ASPIRATE
    JOENSUU, H
    ALANEN, K
    KLEMI, PJ
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (01) : 29 - 33
  • [42] An odd curiosity: Meristematic tissue in a breast fine-needle aspirate
    Martinez-Giron, Rafael
    Pantanowitz, Liron
    DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (01) : 90 - 91
  • [43] Survival after breast cancer according to pre-diagnosis weight in postmenopausal women.
    Trentham-Dietz, A
    Newcomb, PA
    Egan, KM
    Titus-Ernstoff, L
    Storer, BE
    Baron, JA
    Stampfer, MJ
    Willett, WC
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S110 - S110
  • [44] Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
    Anna Kazarian
    Oleg Blyuss
    Gergana Metodieva
    Aleksandra Gentry-Maharaj
    Andy Ryan
    Elena M Kiseleva
    Olga M Prytomanova
    Ian J Jacobs
    Martin Widschwendter
    Usha Menon
    John F Timms
    British Journal of Cancer, 2017, 116 : 501 - 508
  • [45] Cytodiagnosis of microfilaria of the breast from a needle aspirate
    Mehrotra, R
    Singh, M
    Javed, KZ
    Gupta, RK
    ACTA CYTOLOGICA, 1999, 43 (03) : 517 - 518
  • [46] ROLE OF NUCLEAR GRADING OF BREAST CARCINOMAS IN FINE NEEDLE ASPIRATE SPECIMENS
    DABBS, DJ
    LABORATORY INVESTIGATION, 1993, 68 (01) : A28 - A28
  • [47] COMPUTERIZED BREAST-CANCER DIAGNOSIS AND PROGNOSIS FROM FINE-NEEDLE ASPIRATES
    WOLBERG, WH
    STREET, WN
    HEISEY, DM
    MANGASARIAN, OL
    ARCHIVES OF SURGERY, 1995, 130 (05) : 511 - 516
  • [48] Testing breast cancer serum biomarkers for early detection and prognosis in pre-diagnosis samples
    Kazarian, Anna
    Blyuss, Oleg
    Metodieva, Gergana
    Gentry-Maharaj, Aleksandra
    Ryan, Andy
    Kiseleva, Elena M.
    Prytomanova, Olga M.
    Jacobs, Ian J.
    Widschwendter, Martin
    Menon, Usha
    Timms, John F.
    BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 501 - 508
  • [49] Pre-diagnosis diet and survival after a diagnosis of ovarian cancer
    Mary C Playdon
    Christina M Nagle
    Torukiri I Ibiebele
    Leah M Ferrucci
    Melinda M Protani
    Jonathan Carter
    Simon E Hyde
    Deborah Neesham
    James L Nicklin
    Susan T Mayne
    Penelope M Webb
    British Journal of Cancer, 2017, 116 : 1627 - 1637
  • [50] FINE-NEEDLE ASPIRATE DIAGNOSIS OF CILIATED HEPATIC FOREGUT CYSTS
    SELIG, AM
    CHANG, CD
    GALVANEK, EG
    BARDAWIL, RG
    LABORATORY INVESTIGATION, 1994, 70 (01) : A41 - A41